Nano Dimension Updates on Infinite Epigenetics Merger
Money

Nano Dimension Updates on Infinite Epigenetics Merger

authorBy Scott Pape
DateJul 14, 2026
Read Time2 min

Nano Dimension Ltd. (NASDAQ:NNDM) recently provided shareholders with an update on its planned business integration with Infinite Epigenetics. This announcement, made on June 16, 2026, elaborated on the ongoing negotiations and addressed concerns raised by Murchison regarding the transaction.

Nano Dimension emphasized that Infinite Epigenetics is a robust entity, not merely a conceptual venture or an AI shell company. It highlights Infinite's active businesses, a CLIA-certified methylation laboratory, existing revenue streams, a network of over 7,500 healthcare professionals, patented intellectual property, and a proprietary database containing more than 120,000 biological samples. The company also noted Infinite's team has contributed to over 50 publications, and their CLIA-certified lab can process more than one million epigenetic signals from a single sample. This strategic move, chosen from approximately 20 evaluated opportunities, signifies Nano Dimension's shift from 3D printing to AI-driven preventive health and diagnostic solutions.

The proposed merger, which involved an extensive review process with financial, legal, and technological advisors, values Nano Dimension at its net cash plus a 20% premium. It is designed to maintain Nano's Nasdaq listing, preserve the value of its legacy assets through contingent value rights, and offer additional equity upside. Nano Dimension clarified that the transaction does not include separate or deal-specific compensation or payouts, and any definitive agreement will require shareholder approval.

This transformative merger highlights the dynamic nature of technology and investment, where companies adapt and evolve to seize new opportunities. By transitioning into AI-powered health and diagnostics, Nano Dimension is positioning itself at the forefront of innovation, aiming to create long-term value for its stakeholders and contribute to advancements in medical technology.

More Articles
Money
Geron Corporation Grants Stock Options to New Employees
Geron Corporation (NASDAQ: GERN) recently announced the grant of inducement stock options to eight newly hired employees. These options, totaling 690,000 shares, are intended to incentivize new talent and align their interests with the company's long-term success. The exercise price matches the stock's closing price on the grant date, and the options will vest over a four-year period, promoting employee retention and commitment to the oncology-focused biopharmaceutical company.
By Vicki RobinJul 14, 2026
Money
Autolus Therapeutics Bolsters Workforce with New Employee Inducement Awards
Autolus Therapeutics plc (NASDAQ:AUTL) has announced the granting of stock options and restricted stock units to 13 new employees under its 2025 Inducement Plan. These awards, including 25,420 American Depositary Shares and 87,530 restricted stock units, were issued on June 24, 2026, as an incentive for joining the company, aligning with Nasdaq's Listing Rule. This strategic move aims to attract and retain talent, reinforcing the company's growth trajectory and commitment to its therapeutic developments.
By Ramit SethiJul 14, 2026
Money
ECB Selects 36 Payment Firms for Digital Euro Pilot Program
The European Central Bank has chosen 36 payment service providers, including major financial institutions like Deutsche Bank and UniCredit, to participate in the pilot program for its digital euro. Slated to begin in the latter half of 2027 and run for 12 months, the pilot will assess the digital currency's technical viability and operational procedures, aiming for a 2029 launch pending legislative approvals.
By Chika UwazieJul 14, 2026
Money
PowerFleet's AI-Powered SafeGuard Enhances Driver Safety and Company Valuation
PowerFleet Inc. recently launched SafeGuard, an AI-driven risk intelligence solution designed to improve on-road driver behavior, in Australia. This innovation, integrated with their VisionAI video system and Unity platform, utilizes artificial intelligence to pinpoint and address high-risk driving events, significantly reducing incidents and enhancing fleet safety. The company also initiated a $30 million stock repurchase program, signaling confidence in its future, despite a recent adjustment in its price target by Raymond James.
By JL CollinsJul 14, 2026
Money
TON Strategy (TONX) Emerges as a Leading Tech Penny Stock
TON Strategy Co (NASDAQ:TONX) is recognized as one of the fastest-growing technology penny stocks. The company recently announced a Rule 10b5-1 trading plan for common stock repurchase and highlighted the community-led rebrand of Toncoin to "Gram" for The Open Network. This strategic move aims to enhance the network's user understanding and usability, particularly with Telegram-native applications.
By Ramit SethiJul 14, 2026